Deal of the Day — limited-time pharmacy picks!
Daclacure 60mg Tablet

Daclacure 60mg Tablet

Prescription requiredRx Required

Salt Composition: daclatasvir dihydrochloride

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

28 tablet

About The Product

Hepatitis C

Daclacure 60 mg tablet is used for the treatment of chronic hepatitis C virus (HCV). It is an antiviral medication often used along with other medications. This medication lowers the viral dose of the hepatitis C virus (HCV) in the blood.

Uses

Chronic hepatitis C virus (HCV) infection

Side Effects

The human body reacts differently to Declacure 60mg tablet. Response or undesired symptoms vary from individual to individual. Usually, they disappear with time as the body adjusts to the medicine; these side effects don't need special medical attention. Whereas if the symptoms don't disappear with time or you have severe side effects, then consult your doctor immediately.

Some of the common side effects of Declacure 60mg tablet are mentioned below:

  • Headache
  • Nausea
  • Unusual tiredness
  • Anemia
  • Insomnia
  • Dizziness
  • Shortness of breath
  • Irregular heartbeat
  • Chest pain
  • Fatigue Allergic reaction
  • Upset stomach
  • Trouble sleeping
  • Memory problems
  • Low blood sugar
  • Vomiting
  • Abdominal cramps
  • Swelling of the mouth, face, tongue, or throat

How To Use

  • Take the dose of Declacure 60mg tablet as per your healthcare provider’s prescription.
  • Do not stop taking the medicine suddenly, unless your doctor tells you.This medicine is given under the strict supervision of a doctor.
  • Do not self-administer.
  • Overdose is a very unusual state for this medicine because it is given under the supervision of a healthcare provider.
  • Declacure 60mg tablet can be taken without food or with food.
  • The doctor will provide emergency medical treatment.
  • You should not break, crush, or chew the medicine; it should be swallowed as a whole.

How It Works

An antiviral medication, Daclacure tablet, is used for the treatment of Hepatitis C virus (HCV) infection. It works by lowering the viral load from the blood; as a result, Infected individuals feel relief from the related symptoms of the chronic hepatitis C infection.

Daclacure tablet causes a decrease in serum RNA levels of HCV by stopping the function of the nonstructural protein 5A (NS5A) protein in the replication complex. The effect of this medicine can be easily seen within 2 hours after its oral administration.

Safety Advice

Alcohol
It is advised not to consume alcohol with Daclacure 60mg Tablet because the medicine might interact with alcohol, causing harmful effects on the body of the infected individual. Consult your doctor for further information.
Pregnancy
Do not take Daclacure 60mg Tablet without consulting the doctor. In case of pregnancy, taking Daclacure 60mg Tablet might be unsafe. According to some researchers, this medicine may be harmful to the developing baby.
Breast Feeding
Breastfeeding mothers taking Daclacure 60mg Tablet are advised to consult the doctor first before taking this medicine. According to a few researchers, taking Daclacure 60mg Tablet is known to harm the developing baby, as this medicine can pass to the foetus through breast milk.
Driving
It is advisable not to drive or operate heavy machinery, as one of the side effects of the medicine. It is advisable not to drive or operate heavy machinery after taking Daclacure 60mg Tablet, as you may feel dizzy.
Kidney
Please share your medical history with the doctor before starting Daclacure 60mg Tablet. Do not take Daclacure 60mg Tablet without consulting a doctor, as it may worsen the health condition of the individual.
Liver
Share your medical history with the doctor before starting the Daclacure 60mg Tablet. Do not take Daclacure 60mg Tablet without consulting a doctor, as it may worsen the health condition of the individual.

Missed Doses

  • It is advisable not to miss a dose of Daclatasvir Dihydrochloride 60mg Tablet.
  • If you miss a scheduled dose of this medicine, contact your doctor immediately.

FAQs

During pregnancy, it is not safe to take Daclacure 60mg Tablet as it can cause harm to the unborn baby. Also, during breastfeeding, this medicine must not be used.

Please make sure to consult your healthcare provider regarding the same.

Reference

  • Gandhi Y, Eley T, Fura A, Li W, Bertz RJ, Garimella T. (2024). Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics. Clin Pharmacokinet. 57(8):911-928 - https://pubmed.ncbi.nlm.nih.gov/29353349/
  • Eley T, Garimella T, Li W, Bertz RJ. (2023). Asunaprevir: A Review of Preclinical and Clinical Pharmacokinetics and Drug-Drug Interactions. Clin Pharmacokinet. 54(12):1205-22 - https://pubmed.ncbi.nlm.nih.gov/26177803/
  • Talavera Pons S, Boyer A, Lamblin G, Chennell P, Châtenet FT, Nicolas C, Sautou V, Abergel A. (2025). Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C. Br J Clin Pharmacol. 83(2):269-293 - https://pubmed.ncbi.nlm.nih.gov/27530469/
  • Kiang TKL. (2024). Clinical Pharmacokinetics and Drug-Drug Interactions of Elbasvir/Grazoprevir. Eur J Drug Metab Pharmacokinet. 43(5):509-531.
  • Feng HP, Guo Z, Ross LL, Fraser I, Panebianco D, Jumes P, Fandozzi C, Caro L, Talaty J, Ma J, Mangin E, Huang X, Marshall WL, Butterton JR, Iwamoto M, Yeh WW. (2023). Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir. J Antimicrob Chemother. 74(3):710-717.
  • De Bellis E, Donnarumma D, Zarrella A, Mazzeo SM, Pagano A, Manzo V, Mazza I, Sabbatino F, Corbi G, Pagliano P, Filippelli A, Conti V. (2024). Drug-Drug Interactions Between HIV Antivirals and Concomitant Drugs in HIV Patients: What We Know and What We Need to Know. Pharmaceutics. 17(1):31 - https://pubmed.ncbi.nlm.nih.gov/39861680/
  • Priyanka PSSL, Varma DM, Immadisetti K, Rajesh R, Vidyasagar S, Guddattu V. (2023). Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications. Int J Risk Saf Med. 29(1-2):25-55 - https://pubmed.ncbi.nlm.nih.gov/28885219/

Certified Content

Written By
Venika Choudhary

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By
Dr. Aditya Sarin

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026